NCT00786812View on ClinicalTrials.gov

Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Chronic Myeloid Leukemia
Interventions
DRUG

Nilotinib

Trial Locations (9)

30130-100

Novartis Investigative Site, Belo Horizonte

80060-900

Novartis Investigative Site, Curitiba

20230-130

Novartis Investigative Site, Rio de Janeiro

90035-903

Novartis Investigative Site, Porto Alegre

13083-970

Novartis Investigative Site, Campinas

17210-080

Novartis Investigative Site, Jaú

14048-900

Novartis Investigative Site, Ribeirão Preto

01401-901

Novartis Investigative Site, São Paulo

05403-000

Novartis Investigative Site, São Paulo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY